Lixte Biotechnology Holdings, Inc.

• Cover
  • Document and Entity Information
• Financial Statements
  • Condensed Consolidated Balance Sheets
  • Condensed Consolidated Balance Sheets (Parenthetical)
  • Condensed Consolidated Statements of Operations (Unaudited)
  • Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)
  • Condensed Consolidated Statement of Stockholders' Equity (Unaudited)
  • Condensed Consolidated Statements of Cash Flows
• Notes to Financial Statements
  • Organization and Basis of Presentation
  • Business
  • Summary of Significant Accounting Policies
  • Stockholders' Equity
  • Related Party Transactions
  • Stock-Based Compensation
  • Commitments and Contingencies
  • Subsequent Events
• Accounting Policies
  • Summary of Significant Accounting Policies (Policies)
• Notes Tables
  • Summary of Significant Accounting Policies (Tables)
  • Stock-Based Compensation (Tables)
  • Commitments and Contingencies (Tables)
• Notes Details
  • Business (Details Narrative)
  • Summary of Significant Accounting Policies (Details Narrative)
  • Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)
  • Stockholders' Equity (Details Narrative)
  • Related Party Transactions (Details Narrative)
  • Stock-Based Compensation (Details Narrative)
  • Stock-Based Compensation - Schedule of Fair Value of Each Option Award Estimated Assumption (Details)
  • Stock-Based Compensation - Summary of Stock Option Activity (Details)
  • Stock-Based Compensation - Exercise Prices of Common Stock Options Outstanding and Exercisable (Details)
  • Commitments and Contingencies (Details Narrative)
  • Commitments and Contingencies - Schedule of Principal Cash Obligations and Commitments (Details)
  • Subsequent Events (Details Narrative)
• All Reports

Filing Date: 05-10-2017 Form Type: Form 10-Q Description: Quarterly Report